December 4, 2014

The year 2015 bodes well for retail pharmacy in terms of how health care is evolving.

December 3, 2014

The Food and Drug Administration published a final rule that sets standards for how information about using medicines during pregnancy and breastfeeding is presented in the labeling of prescription drugs and biological products.

 

December 3, 2014

Health-and-wellness companies see increasing opportunity in the point-of-care channel to reach and engage with patients primed to receive information about their health.

 

December 3, 2014

In support of National Influenza Vaccination Week, Rite Aid is reducing the price of flu shots by $5 to encourage people who have not yet received their annual flu shot to get vaccinated.

 

December 3, 2014

Thompson Brands on Tuesday announced the launch of an improved formula for its Adora Calcium Supplement.

December 3, 2014

Walgreens announced the launch of its private-label wearables device on YouTube.

 

December 2, 2014

Perrigo on Tuesday announced that it has received final approval from the Food and Drug Administration on its abbreviated new drug application for diclofenac sodium topical solution 1.5% w/w.

December 2, 2014

Ranbaxy Laboratories on Monday announced the launch of Infimab (BOW015), the first Remicade (Infliximab) biosimilar in India. The product was launched at the Indian Rheumatology Association Conference in Chandigarh.

December 1, 2014

Ansell Healthcare on Friday announced the launch of the #UniteToFightHIV, a social media campaign in partnership with the AIDS Healthcare Foundation to raise awareness for World AIDS Day on Dec. 1.

December 1, 2014

Drug Store News will be tweeting key messages from retail pharmacy industry heavyweights.

December 1, 2014

NACDS advocated for the voluntary ability of pharmacies to extend their reward and loyalty programs to beneficiaries in government programs.

December 1, 2014

This flu season, Rexall has partnered with Amref Health Africa to launch “Shot For Shot,” a campaign committed to providing life-saving vaccinations to children that need it most.

December 1, 2014

Teva Pharmaceutical on Monday announced the launch of a generic version of Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) tablets in the United States. 

November 26, 2014

Just 30% of Americans with HIV had the virus under control in 2011, and approximately two-thirds of those whose virus was out of control had been diagnosed but were no longer in care.

November 26, 2014

PharmaArmor announced a Kickstarter campaign for a pill case targeted specifically at travelers. 

November 25, 2014

The Council for Responsible Nutrition on Monday announced the next in its series of free webinars for pharmacists and nurse practitioners, presented in partnership with Skipta.

 

November 25, 2014

Recently, NACDS provided a summary of the 2014 midterm elections, with an emphasis on the federal level. This memo includes an overview of the state elections, which will shape the operating environment on pivotal state issues.

November 25, 2014

Mylan on Tuesday confirmed that it — along with several subsidiaries — has been sued by Baxter International, Baxter Healthcare Corp. and Baxter Healthcare S.A. in relation to the filing of an abbreviated new drug application for the generic version of Brevibloc. 

November 24, 2014

Dr. Reddy's Labs on Monday announced the launch of docetaxel injection USP in 20-mg and 80-mg dosage strengths. The drug is the generic version of Taxotere.

 

November 24, 2014

Perrigo on Monday announced that it has agreed to market the authorized generic version of Astellas U.S.' Protopic ointment 0.1% and 0.03%. 

November 21, 2014

A study being published in Annals of Internal Medicine suggests that people with atrial fibrillation who take NSAIDs may be at risk for serious bleeding or thromboembolisms. 

November 20, 2014

Amneal Pharmaceuticals on Thursday announced the launch of Lopreeza (estradiol/norethindrone acetate) tablets in 0.5-mg and 1-mg dosage strengths. The product is the first authorized generic of Activella from Novo Nordisk.

 

November 20, 2014

CVS Health announced on Thursday that the company and its foundation has committed to invest more than $1 million in grants to support tobacco cessation and prevention programs.

November 20, 2014

Dr. Reddy’s Labs announced Thursday that it has launched a bioequivalent generic version of Allegra-D 12 Hour Allergy and Congestion, in the U.S. market.